Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bupropion ameliorates methamphetamine dependence in some patients

Dec. 28, 2007

Preliminary phase I results with AT-9283 in hematological malignancies encouraging

Dec. 28, 2007

Activity seen with SNS-595 in acute leukemia patients

Dec. 28, 2007

Phase I/II study of Oncohist in leukemia progresses

Dec. 28, 2007

Adjunctive N-acetyl cysteine beneficial in schizophrenia patients

Dec. 27, 2007

Btk inhibition with PCI-32765 evaluated in mouse lymphoma models

Dec. 27, 2007

AC-220 well tolerated in phase I acute myeloid leukemia study

Dec. 27, 2007

Tamoxifen evaluated as anti-mania treatment in women with bipolar affective disorder

Dec. 24, 2007

Raloxifene may benefit postmenopausal women with schizophrenia

Dec. 24, 2007

Encouraging results seen with bevacizumab in glioblastoma multiforme

Dec. 24, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...